Safety and efficacy of varicella zoster immune globulin (human) VariZIG in patients at-risk of varicella infection.
Phase of Trial: Phase III
Latest Information Update: 03 Apr 2013
At a glance
- Drugs Varicella zoster immune globulin (Primary)
- Indications Chickenpox; Herpes zoster
- Focus Therapeutic Use
- 08 Dec 2008 Planned end date changed from 1 Jul 2007 to 1 Dec 2009 as reported by ClinicalTrials.gov.
- 08 Oct 2006 New trial record.